Law ❯Securities Law ❯Class Action Lawsuit
BIVI Disclosure BIVI Investors Phase 3 Clinical Trial False Statements Lead Plaintiff
Investors are urged to secure counsel before the March 19 deadline amid claims of misleading statements related to a clinical trial.
